Patient safety is at the heart of COVID-19 vaccine R & D
As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is continuingworking around the clock to research, develop and manufacture vaccines to prevent infection. To date, substantial progress has been made in vaccinating Americans with COVID-19 vaccines that have been granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA).
Source: The Catalyst - Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development Vaccines Coronavirus Source Type: news
More News: Cardiology | Coronavirus | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Heart | Pandemics | Pharmaceuticals | Vaccines